Nguyen L, Leiser S, Song D, Brunner D, Roberds S, Wong M
Epilepsy Res. 2022; 181:106890.
PMID: 35219048
PMC: 8930622.
DOI: 10.1016/j.eplepsyres.2022.106890.
Kong L, Hoshi N, Sui Y, Yamada Y, Yoshida R, Ooi M
Med Princ Pract. 2021; 31(1):39-46.
PMID: 34818236
PMC: 8995667.
DOI: 10.1159/000518621.
Kapfhamer D, McKenna J, Yoon C, Murray-Stewart T, Casero R, Gambello M
Hum Mol Genet. 2020; 29(14):2395-2407.
PMID: 32588887
PMC: 7424721.
DOI: 10.1093/hmg/ddaa121.
Martin P, Wagh V, Reis S, Erdin S, Beauchamp R, Shaikh G
Mol Autism. 2020; 11(1):2.
PMID: 31921404
PMC: 6945400.
DOI: 10.1186/s13229-019-0311-3.
Bongaarts A, van Scheppingen J, Korotkov A, Mijnsbergen C, Anink J, Jansen F
Brain. 2019; 143(1):131-149.
PMID: 31834371
PMC: 6935755.
DOI: 10.1093/brain/awz370.
Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent biallelic inactivation, and no mutations.
Bongaarts A, Giannikou K, Reinten R, Anink J, Mills J, Jansen F
Oncotarget. 2017; 8(56):95516-95529.
PMID: 29221145
PMC: 5707039.
DOI: 10.18632/oncotarget.20764.
Unilateral giant renal angiomyolipoma and pulmonary lymphangioleiomyomatosis.
de Campos F, Ferreira C, Braz Simoes A, Martins De Alcantara P, Martines B, Ferreira da Silva A
Autops Case Rep. 2017; 3(4):53-62.
PMID: 28584808
PMC: 5453662.
DOI: 10.4322/acr.2013.040.
Role of Akt-independent mTORC1 and GSK3β signaling in sublethal NMDA-induced injury and the recovery of neuronal electrophysiology and survival.
Swiatkowski P, Nikolaeva I, Kumar G, Zucco A, Akum B, Patel M
Sci Rep. 2017; 7(1):1539.
PMID: 28484273
PMC: 5431483.
DOI: 10.1038/s41598-017-01826-w.
The neural crest lineage as a driver of disease heterogeneity in Tuberous Sclerosis Complex and Lymphangioleiomyomatosis.
Delaney S, Julian L, Stanford W
Front Cell Dev Biol. 2014; 2:69.
PMID: 25505789
PMC: 4243694.
DOI: 10.3389/fcell.2014.00069.
Epilepsy related to developmental tumors and malformations of cortical development.
Aronica E, Crino P
Neurotherapeutics. 2014; 11(2):251-68.
PMID: 24481729
PMC: 3996119.
DOI: 10.1007/s13311-013-0251-0.
BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors.
Prabowo A, Iyer A, Veersema T, Anink J, Schouten-van Meeteren A, Spliet W
Brain Pathol. 2013; 24(1):52-66.
PMID: 23941441
PMC: 8029322.
DOI: 10.1111/bpa.12081.
Somatic mutation, genomic variation, and neurological disease.
Poduri A, Evrony G, Cai X, Walsh C
Science. 2013; 341(6141):1237758.
PMID: 23828942
PMC: 3909954.
DOI: 10.1126/science.1237758.
The E3 ubiquitin ligase protein associated with Myc (Pam) regulates mammalian/mechanistic target of rapamycin complex 1 (mTORC1) signaling in vivo through N- and C-terminal domains.
Han S, Kim S, Bahl S, Li L, Burande C, Smith N
J Biol Chem. 2012; 287(36):30063-72.
PMID: 22798074
PMC: 3436263.
DOI: 10.1074/jbc.M112.353987.
TSC1/TSC2 signaling in the CNS.
Han J, Sahin M
FEBS Lett. 2011; 585(7):973-80.
PMID: 21329690
PMC: 3070766.
DOI: 10.1016/j.febslet.2011.02.001.
Analysis of TSC cortical tubers by deep sequencing of TSC1, TSC2 and KRAS demonstrates that small second-hit mutations in these genes are rare events.
Qin W, Chan J, Vinters H, Mathern G, Franz D, Taillon B
Brain Pathol. 2010; 20(6):1096-105.
PMID: 20633017
PMC: 2951479.
DOI: 10.1111/j.1750-3639.2010.00416.x.
Management of subependymal giant cell tumors in tuberous sclerosis complex: the neurosurgeon's perspective.
Berhouma M
World J Pediatr. 2010; 6(2):103-10.
PMID: 20490765
DOI: 10.1007/s12519-010-0025-2.
The tuberous sclerosis complex.
Orlova K, Crino P
Ann N Y Acad Sci. 2010; 1184:87-105.
PMID: 20146692
PMC: 2892799.
DOI: 10.1111/j.1749-6632.2009.05117.x.
Genetics and molecular biology of tuberous sclerosis complex.
Napolioni V, Curatolo P
Curr Genomics. 2009; 9(7):475-87.
PMID: 19506736
PMC: 2691673.
DOI: 10.2174/138920208786241243.
NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.
James M, Han S, Polizzano C, Plotkin S, Manning B, Stemmer-Rachamimov A
Mol Cell Biol. 2009; 29(15):4250-61.
PMID: 19451225
PMC: 2715803.
DOI: 10.1128/MCB.01581-08.
Pi3K-mTOR signaling and AMOG expression in epilepsy-associated glioneuronal tumors.
Boer K, Troost D, Timmermans W, van Rijen P, Spliet W, Aronica E
Brain Pathol. 2009; 20(1):234-44.
PMID: 19371356
PMC: 8094642.
DOI: 10.1111/j.1750-3639.2009.00268.x.